Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 2/20 | 0.36 |
| ▸ | DHFR | P00374 | 3/20 | 0.36 |
| ▸ | GART | P22102 | 1/20 | 0.35 |
| ▸ | FPGS | Q05932 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24344797 | 1.00 | TYMS (0.36) | TYMSDHFRGARTFPGS | |
| SCHEMBL24344796 | 0.93 | TYMS (0.32) | TYMSDHFR | |
| SCHEMBL25725412 | 0.93 | TYMS (0.32) | TYMSDHFR | |
| SCHEMBL24343434 | 0.89 | TYMS (0.39) | TYMSDHFRGARTFPGS | |
| SCHEMBL25298807 | 0.89 | DHFR (0.41) | DHFRFPGS | |
| SCHEMBL24343805 | 0.89 | DHFR (0.41) | DHFRFPGS | |
| SCHEMBL24344222 | 0.84 | DHFR (0.41) | TYMSDHFRFPGS | |
| SCHEMBL25725125 | 0.83 | TYMS (0.41) | TYMSDHFRGARTFPGS | |
| SCHEMBL24343764 | 0.82 | DHFR (0.35) | DHFR | |
| SCHEMBL25838008 | 0.82 | DHFR (0.43) | TYMSDHFRGARTFPGS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114466-A1 | ANTIFOLATE LINKER-DRUGS AND ANTIBODY-DRUG CONJUGATES | BYONDIS B.V. (NL) | 2025-04-10 | — | — | US | disclosed |
| WO-2023126297-A1 | ANTIFOLATE LINKER-DRUGS AND ANTIBODY-DRUG CONJUGATES | BYONDIS B.V. (NL) | 2023-07-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114466-A1 | ANTIFOLATE LINKER-DRUGS AND ANTIBODY-DRUG CONJUGATES | DHFR, FOLR1, MTHFD2 | TYMS 39/4885DHFR 1/4885GART 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.